Why CannTrust (TSX:TRST) Crashed More Than 20% Yesterday

CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) found itself in some hot water with Health Canada after being non-compliant with some of its regulations.

CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) investors got more bad news on Monday when they learned that the company’s operations were found non-compliant with Health Canada’s regulations.

In its Pelham, Ontario facility, CannTrust had been growing cannabis in rooms that were not yet licensed and still pending approval. Although they did ultimately receiving licenses in April 2019, it didn’t change the fact that the company was growing in the rooms prior to then.

What’s also troubling is that regulators noted that “inaccurate information” was provided by CannTrust employees. As a result of the infractions, Health Canada is holding 5,200 kilograms of dried cannabis that CannTrust previously harvested from those rooms. The company is also voluntarily holding 7,500 kilograms at its Vaughn location, which also has cannabis produced from those rooms.

What Health Canada is doing now is performing quality checks on the samples that have been held at Pelham, which is expected to take at least two weeks. The problem in the interim is that now those products can’t be shipped to customers and patients and will cause shortages until Health Canada releases them — assuming it does so.

CannTrust’s CEO Peter Aceto affirms that the company has made the necessary changes and that it will learn from its mistakes: “We have made many changes to make this right with Health Canada. We made errors in judgement, but the lessons we have learned here will serve us well moving forward.” Some of the changes noted by the company that it plans to make include more employee training, and reviews of the processes done by external advisors.

The company couldn’t provide an estimate as to the potential impact on its financials given the uncertainty around the current hold and when the products will be released.

Key takeaways for investors

There are two big concerns I see from this, neither of which relate to sales, at least not directly.

The first is that these added quality control measures, while important, will add a lot more cost to the company’s income statement. With losses being a big problem in the industry and CannTrust reporting a significant net loss last quarter, it may make it even less likely that the company is able to get to breakeven anytime soon.

The company will likely overcompensate for the audit failure, and while it’s understandable to help win back the trust of investors, it’s going to come at a price.

The other concern is the trust issue. In the cannabis industry, investors are starting to worry that the growth prospects in Canada may not be as good as advertised, and so having and establishing trust is critical for companies.

With CannTrust misleading regulators on its facilities, it damages that trust, and the stock had already been struggling, losing 37% of its value over the past three months entering Monday’s trading session, which is going to make raising capital even more challenging.

It may take some time for the company to win back the trust of investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »